<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="at: [[inbox]]
Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360 Urinary tract infections (UTIs) are frequently encountered in the outpatient and inpatient settings."><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-mlkgi530p-htlin222.vercel.app/api/blog?templateTitle=Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360"><title>Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.acd6336f837a791cf1889bb120dfb142.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.6745139bd1dd7178a8bad363a3760e34.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.101a252d6f18bc2c00cff9040f7146e1.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=search placeholder="請輸入像是：hypertension 之類的來看沒有沒什麼有趣的🎳"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>蜥蜴花園🪴</a></h1><div class=spacer></div><div id=search-icon><p>search</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">搜尋圖示</title><desc id="desc">打開搜尋圖標</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>明亮模式</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>黑暗模式</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360</h1><p class=meta>最後更新於
Feb 23, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Infectious%20Diseases%20-%20Urinary%20Tract%20Infections%20-%20Fast%20Facts%20%20NEJM%20Resident%20360.md rel=noopener>🪚 編輯原始文件</a></p><ul class=tags></ul><p>at: <a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p><a href=#infectious-diseases---urinary-tract-infections---fast-facts--nejm-resident-360><h1 id=infectious-diseases---urinary-tract-infections---fast-facts--nejm-resident-360><span class=hanchor arialabel=Anchor># </span>Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360</h1></a><p>Urinary tract infections (UTIs) are frequently encountered in the outpatient and inpatient settings. UTIs can range in severity and organs involved. With increasing indwelling urinary catheter use, catheter-associated UTIs (CAUTIs) have become a quality and safety measure that can affect reimbursement rates. In this section, we will cover the diagnosis and treatment of the following UTI-associated conditions:</p><ul><li><p>Cystitis</p></li><li><p>Pyelonephritis</p></li><li><p>Prostatitis</p></li><li><p>Catheter-Associated UTI (CAUTI)</p></li></ul><a href=#cystitis><h2 id=cystitis><span class=hanchor arialabel=Anchor># </span>Cystitis</h2></a><p>Acute cystitis is the most common presentation of UTI. Cystitis is more frequent in women and is associated with high recurrence rates. Healthy nonpregnant women with normal urinary tract anatomy and no recent instrumentation (e.g., catheters, stents, endoscopes) are considered to have uncomplicated disease. Uncomplicated cystitis rarely progresses to severe disease or pyelonephritis, even if untreated.</p><a href=#diagnosis><h3 id=diagnosis><span class=hanchor arialabel=Anchor># </span>Diagnosis</h3></a><p><strong>Symptoms</strong> of cystitis include:</p><ul><li><p>dysuria</p></li><li><p>frequency</p></li><li><p>urgency</p></li><li><p>suprapubic pain</p></li><li><p>hematuria</p></li></ul><p>Fever is more suggestive of pyelonephritis. Urethritis and vaginitis can mimic cystitis with symptoms of dysuria, but urethritis or vaginitis are not usually associated with other UTI symptoms.</p><p><strong>Urinalysis</strong> (via dipstick)</p><p>Look for presence of:</p><ul><li><p>leukocyte esterase: enzyme released by white blood cells (WBCs)</p></li><li><p>nitrites: poor sensitivity alone because only some bacteria reduce nitrates to nitrites</p></li><li><p>pyuria: ≥10 WBCs/mm<sup>3</sup> or ≥3 WBCs/high-power field of unspun urine; absence of pyuria has good negative predictive value</p></li></ul><p><strong>Urine culture</strong></p><p>Urine culture confirms the presence of bacteriuria, provides antimicrobial susceptibility, and is indicated for complicated disease.</p><ul><li><p>Traditional cutoff for positive test is >100,000 colony-forming units/mL. However, many women with cystitis have lower counts so this is an insensitive measure.</p></li><li><p><em>Escherichia coli</em> is the most common organism; others include <em>Klebsiella pneumoniae</em>, <em>Proteus mirabilis</em>, and gram-positives such as <em>Staphylococcus saprophyticus</em>, <em>Enterococcus faecalis</em>, and <em>Streptococcus agalactiae</em>.</p></li></ul><p><strong>Asymptomatic bacteriuria:</strong> Be aware of the possibility of asymptomatic bacteriuria, defined by the Infectious Diseases Society of America (IDSA) as “isolation of a specified quantitative count of bacteria in an appropriately collected urine specimen obtained from a person without symptoms or signs referable to urinary infection.” Patients with chronic disabilities causing impaired voiding or with chronic indwelling catheters have a high prevalence of asymptomatic bacteriuria.</p><ul><li><p><strong>Treatment does not improve outcomes and is not indicated</strong> except in pregnant women or patients undergoing urologic procedures with mucosal bleeding.</p></li><li><p>Treatment may be considered (although evidence is poor) in catheter-associated asymptomatic bacteriuria that persists 48 hours after short-term (&lt;3 days) indwelling-catheter removal in women to reduce the risk of subsequent infection.</p></li></ul><p><strong>Sterile pyuria</strong> is the persistent finding of WBCs in the urine in the absence of a positive culture. The differential diagnosis is broad and requires various diagnostic methods and treatment, depending on the cause. One algorithm for the assessment of a patient with sterile pyuria can be found here.</p><a href=#treatment><h3 id=treatment><span class=hanchor arialabel=Anchor># </span>Treatment</h3></a><p>Given the accuracy of symptoms for diagnosis, antibiotics can be given to some patients without in-person assessment. Empiric treatment should be based on local resistance patterns. General IDSA guidelines emphasize minimizing ecologic damage and avoiding selection for drug-resistant organisms.</p><a href=#empiric-treatment-of-acute-uncomplicated-cystitis><h3 id=empiric-treatment-of-acute-uncomplicated-cystitis><span class=hanchor arialabel=Anchor># </span>Empiric Treatment of Acute Uncomplicated Cystitis</h3></a><table><thead><tr><th>Antibiotic</th><th>Regimen</th><th>Notes</th></tr></thead><tbody><tr><td><strong>First-line therapy</strong></td><td></td><td></td></tr><tr><td>Nitrofurantoin</td><td></td><td></td></tr><tr><td>Fosfomycin</td><td>100 mg BID x5 days</td><td></td></tr><tr><td>3 g in a single dose</td><td></td><td></td></tr></tbody></table><ul><li><p>Concentrate adequately only in urine</p></li><li><p>Avoid if suspecting pyelonephritis</p></li></ul><p>|
| Trimethoprim–sulfamethoxazole<br>(TMP-SMX) | 160 mg + 800 mg (double<br>strength) BID x3 days |</p><ul><li><p>More ecologic adverse effects than<br>other first-line agents</p></li><li><p>Avoid if local resistance >20%</p></li><li><p>More common side effects</p></li></ul><p>|
| <strong>Second-line therapy</strong> |
| Fluoroquinolones<br>Ciprofloxacin<br>Levofloxacin | 250 mg BID daily x3 days<br>250 or 500 mg daily x3 days |</p><ul><li><p>Reserve for use other than cystitis</p></li><li><p>Resistance in U.S. rising and high<br>in some regions of the world</p></li></ul><p>|
| Beta-lactams (e.g., amoxicillin–<br>clavulanate, cefdinir, cefaclor,<br>cefpodoxime) | 3–7 days |</p><ul><li><p>Generally inferior efficacy and<br>more adverse effects</p></li><li><p>Alternative when other agents<br>cannot be used</p></li></ul><p>|</p><a href=#abbreviation-bid-twice-a-day><h6 id=abbreviation-bid-twice-a-day><span class=hanchor arialabel=Anchor># </span>Abbreviation: BID, twice a day</h6></a><p>(Adapted from Uncomplicated Urinary Tract Infection. N Engl J Med 2012.)</p><p><strong>Complicated****cystitis</strong> may be associated with more drug–resistant organisms and may require broader-spectrum antibiotics for longer durations. Consider a patient’s prior microbiological data and local resistance patterns when selecting an agent (see pyelonephritis treatment below).</p><p><strong>Recurrent episodes:</strong> Change to another first-line antibiotic if recurrence is within 6 months and review potential nonantimicrobial and antimicrobial strategies for prevention. For example, increasing water intake may help reduce the likelihood of recurrent UTI. </p><a href=#pyelonephritis><h2 id=pyelonephritis><span class=hanchor arialabel=Anchor># </span>Pyelonephritis</h2></a><p>Acute pyelonephritis is inflammation of the renal pelvis and kidney. It is a severe UTI syndrome that can lead to sepsis, septic shock, and death.</p><a href=#diagnosis-1><h3 id=diagnosis-1><span class=hanchor arialabel=Anchor># </span>Diagnosis</h3></a><p><strong>Symptoms</strong></p><ul><li><p>fever (not always present)</p></li><li><p>chills</p></li><li><p>flank pain</p></li><li><p>costovertebral-angle tenderness</p></li><li><p>nausea or vomiting, with or without symptoms of cystitis (up to 20% of patients do not have bladder symptoms)</p></li></ul><p><strong>Testing</strong></p><p>General tests to consider include:</p><ul><li><p>urine culture: main confirmatory test; pathogens are similar to those causing cystitis</p></li><li><p>blood culture: helpful given the high rates of associated bacteremia</p></li><li><p>imaging: can identify complications that require further intervention</p></li><li><ul><li><p>obstruction: ultrasonography for hydronephrosis and CT without contrast for stones</p></li><li><p>abscess and emphysematous infection: CT with contrast</p></li></ul></li></ul><a href=#treatment-1><h3 id=treatment-1><span class=hanchor arialabel=Anchor># </span>Treatment</h3></a><p>The main components of treatment include:</p><ul><li><p>fluid resuscitation (see Resuscitation Fluids in the Critical Care rotation guide)</p></li><li><p>prompt antibiotics</p></li><li><p>source control</p></li></ul><p>Select initial antibiotics based on likelihood of a resistant organism (see algorithm below). Hydronephrosis and abscesses may require percutaneous drainage, and emphysematous pyelonephritis typically requires partial or total nephrectomy. </p><a href=#proposed-algorithm-for-the-selection-of-an-initial-antimicrobial-regimen-for-acute-pyelonephritis><h3 id=proposed-algorithm-for-the-selection-of-an-initial-antimicrobial-regimen-for-acute-pyelonephritis><span class=hanchor arialabel=Anchor># </span>Proposed Algorithm for the Selection of an Initial Antimicrobial Regimen for Acute Pyelonephritis</h3></a><p><strong>(Source: Acute Pyelonephritis in Adults. N Engl J Med 2018.)</strong></p><a href=#antimicrobial-agents-commonly-used-for-treatment-of-acute-pyelonephritis-in-adults><h3 id=antimicrobial-agents-commonly-used-for-treatment-of-acute-pyelonephritis-in-adults><span class=hanchor arialabel=Anchor># </span>Antimicrobial Agents Commonly Used for Treatment of Acute Pyelonephritis in Adults</h3></a><table><thead><tr><th>Antibiotics</th><th>Notes</th></tr></thead><tbody><tr><td>Ciprofloxacin</td><td></td></tr><tr><td>Levofloxacin</td><td></td></tr><tr><td>Trimethoprim–</td><td></td></tr><tr><td>sulfamethoxazole</td><td></td></tr><tr><td>(TMP-SMX)</td><td>Because of possible resistance, initial IV</td></tr><tr><td>administration of a supplemental drug is</td><td></td></tr><tr><td>often warranted</td><td></td></tr></tbody></table><p>Avoid if local resistance >10% |
| Amoxicillin–clavulanate | Active against enterococcus, not for<br>empiric monotherapy |
| Cefixime<br>Cefpodoxime | Active against many fluoroquinolone- and<br>TMP-SMX–resistant gram-negative bacilli</p><p>Little clinical evidence available |
| Piperacillin–tazobactam | Active against some cephalosporin-<br>resistant gram-negative bacilli |
| Ceftriaxone | Active against most fluoroquinolone-<br>resistant gram-negative bacilli |
| Cefepime<br>Ertapenem<br>Meropenem<br>Gentamicin | Active against most fluoroquinolone-<br>and ceftriaxone-resistant gram-negative bacilli |
| Amikacin | Active against many gentamicin-resistant<br>gram-negative bacilli and New Delhi metallo-<br>beta-lactamase |
| Ceftolozane-<br>tazobactam<br>Ceftazidime-avibactam | Active against many resistant gram-<br>negative bacilli, but not New Delhi metallo-<br>beta-lactamase |</p><a href=#adapted-from-acute-pyelonephritis-in-adults-n-engl-j-med-2018><h6 id=adapted-from-acute-pyelonephritis-in-adults-n-engl-j-med-2018><span class=hanchor arialabel=Anchor># </span>(Adapted from Acute Pyelonephritis in Adults. N Engl J Med 2018.)</h6></a><a href=#prostatitis><h2 id=prostatitis><span class=hanchor arialabel=Anchor># </span>Prostatitis</h2></a><p>Prostatitis refers to inflammation of the prostate. Presenting symptoms include pelvic pain, symptoms of cystitis, and obstruction. The National Institute of Health divides prostatitis into four syndromes:</p><ul><li><p><strong>Acute bacterial prostatitis</strong></p></li><li><ul><li><p>more common in adults aged 20 to 40 years and older than 70 years</p></li><li><p>presenting symptoms include fever, perineal pain, symptoms of cystitis, obstruction, and occasionally obstructive uropathy</p></li><li><p>the prostate is tender on exam</p></li><li><p>obtain urine cultures to determine the responsible bacteria</p></li><li><p>can be treated with broad-spectrum IV antibiotics (e.g., piperacillin–tazobactam, ceftriaxone with or without an aminoglycoside) or a fluoroquinolone</p></li></ul></li><li><p><strong>Chronic bacterial prostatitis</strong></p></li><li><ul><li><p>can manifest as recurrent UTIs with the same organism and can be difficult to cure due to poor drug diffusion into the prostate</p></li><li><p>with appropriate suspicion, can be diagnosed with the four-glass Meares–Stamey test</p></li><li><p>usually treated with a fluoroquinolone or TMP-SMX for 30 days</p></li></ul></li><li><p><strong>Chronic nonbacterial prostatitis</strong></p></li><li><ul><li>refers to recurrent symptoms in the presence of inflammation but without bacterial infection of the prostate</li></ul></li><li><p><strong>Asymptomatic inflammatory prostatitis</strong></p></li><li><ul><li>refers to incidental evidence of inflammation of the prostate without any urogenital symptoms</li></ul></li></ul><a href=#catheter-associated-urinary-tract-infection><h2 id=catheter-associated-urinary-tract-infection><span class=hanchor arialabel=Anchor># </span>Catheter-Associated Urinary Tract Infection</h2></a><p>Virtually all health care-associated UTIs are caused by instrumentation of the urinary tract, and catheter-associated urinary tract infections (CAUTIs) increase hospital cost, length of stay, morbidity, and mortality. It’s an important hospital performance measure, and your institution likely has policies to reduce its incidence. The exact case definition has varied over time (see current CDC definition).</p><a href=#prevention-strategies><h3 id=prevention-strategies><span class=hanchor arialabel=Anchor># </span>Prevention Strategies</h3></a><ul><li><p>Insert indwelling urinary catheters only when indicated, such as:</p></li><li><ul><li><p>clinically significant urinary retention or outflow obstruction</p></li><li><p>accurate measurements of urinary output in critically ill patients</p></li><li><p>comfort in terminally ill patients</p></li><li><p>urinary incontinence <strong>is not</strong> an indication unless to heal open sacral or perineal wounds in incontinent patients</p></li></ul></li><li><p>Assess daily need for ongoing catheter use.</p></li><li><p>Consider alternative options such as condom catheter or intermittent catheterization.</p></li><li><p>Use aseptic insertion techniques.</p></li><li><p>Assure there is no obstruction to flow (e.g., keep collecting bag below level of the bladder at all times).</p></li></ul><p><a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>↩️ 反向連結</h3><ul class=backlinks><li><a href=/all-list-of-resident360/ data-ctx="Infectious Diseases - Urinary Tract Infections - Fast Facts  NEJM Resident 360" data-src=/all-list-of-resident360 class=internal-link>all list of resident360</a></li><li><a href=/id/ data-ctx="Infectious Diseases - Urinary Tract Infections - Fast Facts  NEJM Resident 360" data-src=/id class=internal-link>infectious disease</a></li><li><a href=/id-2/ data-ctx="Infectious Diseases - Urinary Tract Infections - Fast Facts  NEJM Resident 360" data-src=/id-2 class=internal-link>infectious disease</a></li><li><a href=/infectious-disease/ data-ctx="Infectious Diseases - Urinary Tract Infections - Fast Facts  NEJM Resident 360" data-src=/infectious-disease class=internal-link>infectious disease</a></li><li><a href=/recent/ data-ctx="Infectious Diseases - Urinary Tract Infections - Fast Facts  NEJM Resident 360" data-src=/recent class=internal-link>recent</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>🤯互動圖</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>本網站是由 Hsieh-Ting Lin 以❤️ 用 <a href=https://github.com/jackyzha0/quartz>Quartz</a>這個酷東西種出來🪴 , © 2023</p><p><a href=https://www.buymeacoffee.com/htl.lizard><img src=https://cdn.buymeacoffee.com/buttons/v2/default-yellow.png width=200></a></p><ul><li><a href=https://www.physician.tw/>🏠首頁</a></li><li><a href=https://www.facebook.com/htlin.lizard>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://htlin222.medium.com>Medium</a></li></ul></footer></div></div></body></html>